Atrial Fibrillation: Drugs
The question
To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the number of patients with atrial fibrillation who are unable to take long-term anticoagulation for the prevention of strokes in (a) Slough and (b) the South East.
Answered by Mrs Sharon Hodgson
No estimate has been made regarding the number of patients with atrial fibrillation who are unable to take long-term anticoagulation for the prevention of strokes in Slough and the South East as this information is not collected. However, clinical consensus suggests that less than 10% of patients with atrial fibrillation have clear contraindications to the use of long-term anticoagulation.
This Government recognises the importance of optimising atrial fibrillation treatment, which can reduce the risk of stroke by up the 64%. The Department and NHS England continue to look to NICE for guidance on the role of long-term anticoagulation for the prevention of strokes, and the approach for those who are unable to take long-term anticoagulation.
Alongside this, the Department will publish the Cardiovascular Disease Modern Service Framework soon, to support greater consistency in the detection, assessment, management and treatment of cardiovascular disease across England.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →